SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Lazare who wrote (139)10/22/1997 5:29:00 AM
From: James Baker   of 569
 
DL: <<57% increase on a small revenue is not significant>>

Dan, I think that this is good progress even if it is from a small base. I think there are only about 4 countries now using Synvisc and any NEW treatment like this does take time for both physicians and patients to get a good feeling about.

US FDA approval is the final step in the true launch for Synvisc (as it will be for Hylaform as well). Just the size of our population and expectation for improved health will make this product soar. OK W/A get out there and make this product available!

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext